Drug Type Biological products |
Synonyms iCP-SOCS3 |
Target |
Action modulators |
Mechanism SOCS3 modulators(suppressor of cytokine signaling 3 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | South Korea | 01 Jan 2019 | |
Glioblastoma | Preclinical | South Korea | 01 Jan 2019 | |
Liver Cancer | Preclinical | South Korea | 01 Jan 2019 | |
Lung Cancer | Preclinical | South Korea | 01 Jan 2019 | |
Pancreatic Cancer | Preclinical | South Korea | 01 Jan 2019 |